|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 413/04 | (2006.01) |
| A61K 31/4439 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Patento numeris | 2454255 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10742897.1 |
| Europos patento paraiškos padavimo data | 2010-07-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-05-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-11-06 |
| (46) | Apibrėžties vertimo paskelbimo data | 2014-02-25 |
| (86) | Numeris | PCT/IB2010/053224 |
| Data | 2010-07-15 |
| (87) | Numeris | WO 2011/007324 |
| Data | 2011-01-20 |
| (30) | Numeris | Data | Šalis |
| PCT/IB2009/0530 | 2009-07-16 | WO |
| (72) |
BOLLI, Martin, CH
LESCOP, Cyrille, CH
MATHYS, Boris, CH
MORRISON, Keith, CH
MUELLER, Claus, CH
NAYLER, Oliver, CH
STEINER, Beat, CH
|
| (73) |
Idorsia Pharmaceuticals Ltd,
Hegenheimermattweg 91, CH-4123 Allschwil,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Piridin-4-ilo dariniai, kaip S1P1/EDG1 agonistai |
| PYRIDIN-4-YL DERIVATIVES AS S1P1/EDG1 AGONISTS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-07-03 | 16 | 347.00 EUR |
| 2026-07-15 |